Preliminary studies are exploring the impact on non-alcoholic fatty liver disease (NAFLD), polycystic ovary syndrome (PCOS), and even neurological conditions such as Alzheimers disease, given the metabolic and neuroprotective potential of both interventions
Its hard to imagine that Point32Health, the next largest commercial insurer with 1.5 million members, will continue to compete with Blue Cross at a significant financial disadvantage by covering expensive GLP-1s
And while metformin has been the first-line therapy in treating type 2 diabetes, the FDA announced in 2019 that Rybelsus (semaglutide), a GLP-1, can also be offered as a first-line treatment
The genetic variable underneath every GLP-1 decision Whichever compound a patient and provider choose, the upstream genetic architecture is shared
Even women with typically regular periods can sometimes experience minor hormonal fluctuations that lead to a late period
Mood swings that creep in without warning